AP857A - Resorcinol derivatives. - Google Patents

Resorcinol derivatives. Download PDF

Info

Publication number
AP857A
AP857A APAP/P/1998/001349A AP9801349A AP857A AP 857 A AP857 A AP 857A AP 9801349 A AP9801349 A AP 9801349A AP 857 A AP857 A AP 857A
Authority
AP
ARIPO
Prior art keywords
formula
compound
alkyl
pharmaceutically acceptable
water
Prior art date
Application number
APAP/P/1998/001349A
Other languages
English (en)
Other versions
AP9801349A0 (en
Inventor
Lan Hu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AP9801349A0 publication Critical patent/AP9801349A0/xx
Application granted granted Critical
Publication of AP857A publication Critical patent/AP857A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1998/001349A 1997-09-23 1998-09-17 Resorcinol derivatives. AP857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5962597P 1997-09-23 1997-09-23

Publications (2)

Publication Number Publication Date
AP9801349A0 AP9801349A0 (en) 1998-09-30
AP857A true AP857A (en) 2000-07-11

Family

ID=22024176

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001349A AP857A (en) 1997-09-23 1998-09-17 Resorcinol derivatives.

Country Status (46)

Country Link
US (1) US6132740A (es)
EP (1) EP0904774B1 (es)
JP (2) JP3591763B2 (es)
KR (1) KR100373996B1 (es)
CN (1) CN1176647C (es)
AP (1) AP857A (es)
AR (1) AR012520A1 (es)
AT (1) ATE235220T1 (es)
AU (1) AU735716C (es)
BG (1) BG64524B1 (es)
BR (1) BR9803596A (es)
CA (1) CA2247748C (es)
CO (1) CO5070677A1 (es)
CZ (1) CZ297669B6 (es)
DE (1) DE69812519T2 (es)
DK (1) DK0904774T3 (es)
DZ (1) DZ2614A1 (es)
EA (1) EA003576B1 (es)
EG (1) EG23860A (es)
ES (1) ES2192301T3 (es)
GT (1) GT199800150A (es)
HK (1) HK1028344A1 (es)
HR (1) HRP20000168B1 (es)
HU (1) HUP0003743A3 (es)
ID (1) ID24084A (es)
IL (2) IL134598A0 (es)
IS (1) IS2280B (es)
MA (1) MA26548A1 (es)
MY (1) MY117805A (es)
NO (1) NO327177B1 (es)
NZ (1) NZ502797A (es)
OA (1) OA11334A (es)
PA (1) PA8459901A1 (es)
PE (1) PE117299A1 (es)
PL (1) PL195192B1 (es)
PT (1) PT904774E (es)
SA (1) SA98190724B1 (es)
SI (1) SI0904774T1 (es)
SK (1) SK284983B6 (es)
TN (1) TNSN98176A1 (es)
TR (1) TR200000782T2 (es)
TW (1) TW585780B (es)
UA (1) UA57106C2 (es)
UY (2) UY25191A1 (es)
WO (1) WO1999015148A1 (es)
ZA (1) ZA988669B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
FR2777183B1 (fr) * 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
SK13302001A3 (sk) * 1999-03-22 2002-12-03 Pfizer Inc. Deriváty rezorcinolu
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
HN2000000033A (es) * 1999-03-22 2001-02-02 Pfizer Prod Inc Composicion de resorcinol
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
JP4615671B2 (ja) * 2000-04-20 2011-01-19 ポーラ化成工業株式会社 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
ATE281431T1 (de) * 2000-09-11 2004-11-15 Pfizer Prod Inc Resorcin-derivate
CA2423262A1 (en) * 2000-09-21 2002-03-28 Pfizer Products Inc. Resorcinol derivatives
US6514506B1 (en) * 2001-02-14 2003-02-04 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
MY134040A (en) 2001-05-02 2007-11-30 Univ New York Inhibition of pigmentation by inhibition of fatty acid synthase
CA2445647A1 (en) * 2001-05-25 2002-12-05 P&G-Clairol, Inc. 1,3-dihydroxybenzene derivatives and colorants containing said compounds
US6863897B2 (en) * 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
US7378232B2 (en) * 2002-05-09 2008-05-27 New York University Assay for melanogenesis
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US6852310B2 (en) * 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
US7524485B2 (en) * 2002-12-12 2009-04-28 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
BRPI0407193A (pt) * 2003-02-03 2006-02-14 Warner Lambert Co formulação aperfeiçoada para agentes de clareamento da pele
US7338979B2 (en) * 2003-02-11 2008-03-04 Warner-Lambert Company Depigmentation agents
WO2004103940A1 (en) * 2003-05-20 2004-12-02 Warner-Lambert Company Llc Depigmenting agents
EP1626702A2 (en) * 2003-05-26 2006-02-22 Enprani Co., Ltd. Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same
EP2236131A3 (en) 2003-07-01 2011-03-02 President and Fellows of Harvard College Sirt1 modulators for manipulating cell/organism lifespan/stress response
DE602004017747D1 (de) * 2003-07-08 2008-12-24 Unilever Nv Verfahren zur herstellung einer kosmetisch aktiven verbindung
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1708689A2 (en) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US7300646B2 (en) * 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
KR101236527B1 (ko) 2004-05-28 2013-02-22 유니젠, 인크. 이핵성 효소의 강력한 저해제로서의 디아릴알칸
WO2006029484A1 (en) * 2004-09-14 2006-03-23 Ajinomoto Omnichem S.A. Topical compositions containing phosphorylated polyphenols
JP5093998B2 (ja) * 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
WO2007077770A1 (ja) * 2005-12-26 2007-07-12 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo アルキルレゾルシノール配糖体とその製造方法並びに用途
EP1973518A1 (en) * 2006-01-05 2008-10-01 Symrise GmbH & Co. KG Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
WO2007148472A1 (ja) * 2006-06-19 2007-12-27 Kuraray Co., Ltd. 安定性に優れた皮膚外用剤
JP4990574B2 (ja) * 2006-07-13 2012-08-01 ポーラ化成工業株式会社 新規化合物及びそれを含有する皮膚外用剤
JP5132095B2 (ja) * 2006-07-13 2013-01-30 ポーラ化成工業株式会社 エマルション剤形の皮膚外用剤
DE102007038098A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
DE102007038097A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
WO2009064492A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Quinoline compounds as melanogenesis modifiers and uses thereof
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
US20100040568A1 (en) * 2008-04-30 2010-02-18 Skinmedica, Inc. Steroidal compounds as melanogenesis modifiers and uses thereof
US20100010100A1 (en) * 2008-07-09 2010-01-14 Hinman Andrew W Dermatological compositions with anti-aging and skin even-toning properties
JP2011528719A (ja) * 2008-07-21 2011-11-24 ユニジェン・インコーポレーテッド スキンホワイトニング（色を薄くする）化合物系列
US20100029784A1 (en) * 2008-07-30 2010-02-04 Hinman Andrew W Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
FR2939136B1 (fr) 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2953834B1 (fr) 2009-12-10 2012-01-13 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP4825921B1 (ja) * 2010-07-16 2011-11-30 株式会社 資生堂 ４−アルキルレゾルシノール誘導体及びこれを含有する皮膚外用剤
WO2012103487A1 (en) 2011-01-27 2012-08-02 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
CN103492353A (zh) 2011-03-24 2014-01-01 尤尼根公司 用于制备二芳基丙烷的化合物和方法
CA2902506A1 (en) 2013-03-08 2014-09-12 Unilever Plc Resorcinol compounds for dermatological use
RU2582215C1 (ru) * 2015-01-16 2016-04-20 Александр Ливиевич Ураков Способ обесцвечивания кожи в области кровоподтека
WO2017079905A1 (en) * 2015-11-10 2017-05-18 Henkel Ag & Co. Kgaa A cosmetic composition for skin brightening
JP7009392B2 (ja) 2016-06-15 2022-01-25 ユニリーバー・アイピー・ホールディングス・ベー・フェー アルキル置換レゾルシノールの経皮送達促進のための方法及び化粧品組成物
CN109789066A (zh) * 2016-06-30 2019-05-21 西姆莱斯股份公司 含有间苯二酚衍生物的药物和化妆组合物
CN110868993A (zh) * 2017-07-12 2020-03-06 荷兰联合利华有限公司 皮肤组合物增效油
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
WO2021008823A1 (en) 2019-07-12 2021-01-21 Unilever Plc Stabilization of resorcinol compounds in cosmetic compositions
CN114599340B (zh) * 2019-10-30 2024-04-30 陶氏环球技术有限责任公司 具有中空介孔二氧化硅纳米球的防晒组合物
CN115484921A (zh) 2020-04-28 2022-12-16 联合利华知识产权控股有限公司 N,n′-二乙酰基胱氨酸内稳定的化妆品组合物
CN114315527B (zh) * 2021-12-29 2024-06-11 苏州博研医药科技有限公司 一种间苯二酚的制备方法
WO2024132395A1 (en) 2022-12-21 2024-06-27 Unilever Ip Holdings B.V. Color stabilization of formulae with an indole

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011119A1 (en) * 1990-02-05 1991-08-08 Opta Food Ingredients, Inc. Compositions and methods for inhibiting browning in foods
EP0623339A1 (fr) * 1993-04-29 1994-11-09 L'oreal Utilisation de dérivés de la resorcine substitués en position(s)4,4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131200A (en) * 1966-06-06 1968-10-23 Fuji Photo Film Co Ltd Process for the production of polymer images by the polymerization of vinyl compounds
GB1221325A (en) * 1967-04-06 1971-02-03 Fuji Photo Film Co Ltd Dormation of dye images from photographic images
US3933925A (en) * 1972-06-29 1976-01-20 Koppers Company, Inc. Hydrolysis of toluene diamines to produce methyl resorcinols
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
DE2616479C2 (de) * 1976-04-14 1986-12-04 Brickl, Rolf, Dr., 7951 Warthausen Substituierte Fluoracylresorcine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel und Kosmetika
DE3127590A1 (de) * 1980-07-12 1982-08-12 Kozak, Pavel, 6600 Saarbrücken Mittel fuer die externe behandlung von hautkrakheiten
US4391827A (en) * 1980-09-08 1983-07-05 Pfizer Inc. 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
DE3604865A1 (de) * 1986-02-15 1987-08-20 Walter Dr Med Langbehn Haut-kosmetikum
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
US4985157A (en) * 1989-05-01 1991-01-15 Mobil Oil Corporation Mixed alkoxylated alcohol-hydroquinone/resorcinol borates-antioxidants
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
JP2801960B2 (ja) * 1990-10-31 1998-09-21 ポーラ化成工業株式会社 頭髪化粧料
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
EP0524439A1 (en) * 1991-07-24 1993-01-27 F.Hoffmann-La Roche & Co. Aktiengesellschaft Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
CA2094465A1 (en) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Cycloalkane derivatives
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
JPH0656641A (ja) * 1992-08-05 1994-03-01 Nippon Paint Co Ltd 化粧料
FR2704753B1 (fr) * 1993-05-06 1995-06-30 Oreal Utilisation de derives de la 4-thio resorcine ou 4-thio 1-3-dihydroxybenzene, dans des compositions cosmetiques ou dermopharmaceutiques a action depigmentante.
GB9418762D0 (en) * 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011119A1 (en) * 1990-02-05 1991-08-08 Opta Food Ingredients, Inc. Compositions and methods for inhibiting browning in foods
EP0623339A1 (fr) * 1993-04-29 1994-11-09 L'oreal Utilisation de dérivés de la resorcine substitués en position(s)4,4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante

Also Published As

Publication number Publication date
BG64524B1 (bg) 2005-06-30
EP0904774A1 (en) 1999-03-31
PA8459901A1 (es) 2000-05-24
EA003576B1 (ru) 2003-06-26
HK1028344A1 (en) 2001-02-16
AU735716B2 (en) 2001-07-12
UA57106C2 (uk) 2003-06-16
OA11334A (en) 2003-12-10
CZ297669B6 (cs) 2007-02-28
CA2247748A1 (en) 1999-03-23
CO5070677A1 (es) 2001-08-28
IS5376A (is) 2000-02-15
ES2192301T3 (es) 2003-10-01
MY117805A (en) 2004-08-30
SK3782000A3 (en) 2001-06-11
CN1176647C (zh) 2004-11-24
JP3591763B2 (ja) 2004-11-24
AU8994698A (en) 1999-04-12
JPH11152203A (ja) 1999-06-08
SK284983B6 (sk) 2006-03-02
EP0904774B1 (en) 2003-03-26
PL195192B1 (pl) 2007-08-31
HUP0003743A3 (en) 2006-02-28
ID24084A (id) 2000-07-06
SA98190724B1 (ar) 2006-05-20
NZ502797A (en) 2002-04-26
HRP20000168A2 (en) 2000-08-31
EA200000251A1 (ru) 2000-08-28
CN1270509A (zh) 2000-10-18
CZ20001037A3 (cs) 2001-02-14
UY25191A1 (es) 2001-08-27
ZA988669B (en) 2000-03-22
PE117299A1 (es) 1999-11-18
TR200000782T2 (tr) 2000-09-21
KR20010024217A (ko) 2001-03-26
SI0904774T1 (en) 2003-10-31
JP2004210799A (ja) 2004-07-29
NO20001473L (no) 2000-03-22
IL134598A0 (en) 2001-04-30
DZ2614A1 (fr) 2003-03-01
BG104247A (en) 2000-11-30
AR012520A1 (es) 2000-10-18
NO20001473D0 (no) 2000-03-22
GT199800150A (es) 2000-03-15
HRP20000168B1 (en) 2006-07-31
KR100373996B1 (ko) 2003-02-26
IL170545A (en) 2010-04-29
PT904774E (pt) 2003-08-29
EG23860A (en) 2007-11-18
TNSN98176A1 (fr) 2005-03-15
ATE235220T1 (de) 2003-04-15
DE69812519T2 (de) 2003-12-11
PL339551A1 (en) 2000-12-18
TW585780B (en) 2004-05-01
DK0904774T3 (da) 2003-06-16
CA2247748C (en) 2002-07-02
UY25550A1 (es) 2000-02-23
BR9803596A (pt) 2000-04-25
NO327177B1 (no) 2009-05-04
US6132740A (en) 2000-10-17
AU735716C (en) 2007-03-29
IS2280B (is) 2007-09-15
WO1999015148A1 (en) 1999-04-01
AP9801349A0 (en) 1998-09-30
HUP0003743A2 (hu) 2001-04-28
MA26548A1 (fr) 2004-12-20
DE69812519D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
AP857A (en) Resorcinol derivatives.
AU765209B2 (en) Resorcinol composition
US5730962A (en) Depigmenting cosmetic or dermatologic composition containing a benzofuran derivative and its use in depigmentating skin
MXPA98007778A (es) Derivados de resorcinol
MXPA01009546A (es) Composicion de resorcinol